Javascript must be enabled to continue!
SCREENING FOR GENETIC MUTATIONS IN LDLR GENE WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE MONGOLIAN POPULATION
View through CrossRef
Abstract
Objective:
The objective of this study was to characterize LDLR (low density lipoprotein receptor) gene mutation in patients with familial hypercholesterolemia.
Design and method:
Methods: This cross-sectional study was included subjects aged from 20 to 64 years, with a clinical diagnosis of familial hypercholesterolemia. Clinical diagnosis of familial hypercholesterolemia was based on Dutch Lipid Clinic Network diagnostic criteria. Possible and probable familial hypercholesterolemia were defined as a total score was 3–5 and 6–8 points. Ten ml of venous blood samples were collected from all the subjects and used for biochemical and genetic analysis. Deoxyribonucleic acid was isolated from peripheral blood samples and precise primers were designed for LDLR gene which includes 18 exons. Polymerize chain reaction test was followed by deoxyribonucleic acid sequence analysis.
Results:
Results: A total of 89 subjects included in the study of which, 32 (36%) were men and 57 (64%) were women. The mean age of the participants was 46.5 ± 7.8 years. In our study, we found the following 3 LDLR mutations: S265R mutation in Exon-6, C308Y mutation Exon-8 and V502 M mutation in Exon-10.
Conclusions:
Conclusion: This was the first study to identify genetic mutations in LDLR gene in Mongolia. We conclude that screening of family hypercholesterolemia among the Mongolian population is very important to identify individuals who are prone to develop the atherosclerotic cardiovascular disease.
Ovid Technologies (Wolters Kluwer Health)
Title: SCREENING FOR GENETIC MUTATIONS IN LDLR GENE WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE MONGOLIAN POPULATION
Description:
Abstract
Objective:
The objective of this study was to characterize LDLR (low density lipoprotein receptor) gene mutation in patients with familial hypercholesterolemia.
Design and method:
Methods: This cross-sectional study was included subjects aged from 20 to 64 years, with a clinical diagnosis of familial hypercholesterolemia.
Clinical diagnosis of familial hypercholesterolemia was based on Dutch Lipid Clinic Network diagnostic criteria.
Possible and probable familial hypercholesterolemia were defined as a total score was 3–5 and 6–8 points.
Ten ml of venous blood samples were collected from all the subjects and used for biochemical and genetic analysis.
Deoxyribonucleic acid was isolated from peripheral blood samples and precise primers were designed for LDLR gene which includes 18 exons.
Polymerize chain reaction test was followed by deoxyribonucleic acid sequence analysis.
Results:
Results: A total of 89 subjects included in the study of which, 32 (36%) were men and 57 (64%) were women.
The mean age of the participants was 46.
5 ± 7.
8 years.
In our study, we found the following 3 LDLR mutations: S265R mutation in Exon-6, C308Y mutation Exon-8 and V502 M mutation in Exon-10.
Conclusions:
Conclusion: This was the first study to identify genetic mutations in LDLR gene in Mongolia.
We conclude that screening of family hypercholesterolemia among the Mongolian population is very important to identify individuals who are prone to develop the atherosclerotic cardiovascular disease.
Related Results
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation
Abstract
Background
Familial hypercholesterolemia (FH) is a genetic condition characterized by elevated LDL-C and increased cardiovascular risk. ...
Abstract 228: A Novel Combinatorial Non-viral Vector to Treat Familial Hypercholesterolaemia
Abstract 228: A Novel Combinatorial Non-viral Vector to Treat Familial Hypercholesterolaemia
Familial hypercholesterolaemia (FH) is a life-threatening genetic disorder characterised by elevated levels of plasma low density lipoprotein cholesterol (LDL-C). Loss-of-function ...
Mutation Analysis of the LDL Receptor Gene in Indian Families with Familial Hypercholesterolemia
Mutation Analysis of the LDL Receptor Gene in Indian Families with Familial Hypercholesterolemia
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal dominant trait characterized by an increased plasma low-density lipoprotein (LDL) le...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Variants in the LDLR and the APOB genes in patients with familial hypercholesterolemia in the Republic of Sakha (Yakutia)
Variants in the LDLR and the APOB genes in patients with familial hypercholesterolemia in the Republic of Sakha (Yakutia)
The aim of the study. Molecular genetic studies of familial hypercholesterolemia (FH) have been conducted in different regions of the Russian Federation for several decades. Howeve...
Diachronic Study on the Origin of Mongolian word алим “apple” in Terms of Phonology, Morphology, Semantics and Linguistic Distribution
Diachronic Study on the Origin of Mongolian word алим “apple” in Terms of Phonology, Morphology, Semantics and Linguistic Distribution
In this paper we attempted to find out the origin of Mongolian word алим “apple” in terms of phonology, morphology, semantics and linguistic distribution. As a result of the resear...
PCSK-9 Inhibitors
PCSK-9 Inhibitors
Hyperlipidemia (elevated levels of LDL-C) is a well-known risk factor of cardiovascular diseases (CVD). Statins are well known and proven drugs for the lipid management of those wh...
Immune system humanization in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice controls atherosclerosis
Immune system humanization in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice controls atherosclerosis
Abstract
Background and aim
Given the key role of the immune response during atherosclerosis and the therapeutic interest of bio...

